Literature DB >> 14594115

Human placenta and fetal membranes express follistatin-related gene mRNA and protein.

P Ciarmela1, P Florio, P Toti, A Franchini, V Maguer-Satta, C Ginanneschi, E Ottaviani, F Petraglia.   

Abstract

Activin A is a placental glycoprotein and possible biological actions during pregnancy, suggested by experimental data, are the modulation of cytotrophoblast differentiation, placental hormonogenesis and uterotonins secretion. Follistatin-related gene (FLRG) is a 70 amino acids protein which binds activin A with high affinity, and which modulates its biological effects on target tissues by preventing the activin A interaction with its receptors. The present study investigated whether trophoblast, decidua and fetal membranes express FLRG mRNA (by RT-PCR) and peptide (by immunohistochemistry). Tissue specimens were collected at first and third trimester of pregnancy, from patients undergoing voluntary pregnancy interruption (no.=6; from 8 to 12 gestational weeks) and elective caesarean section at term (no.=6; 39-40 weeks of pregnancy). FLRG mRNA was expressed by the various gestational tissues both at early gestation and at term pregnancy. Immunoreactive protein was found in the trophoblast cells, epithelial amniotic and chorionic cells and maternal decidua; nevertheless, the most intense FLRG stain was detected in the walls of decidual and placental blood vessels. In conclusion, FLRG mRNA and peptide are expressed by placenta and fetal membranes. Its different immunolocalization with respect to follistatin and activin A supports a different role for FLRG in modulating activin A actions into gestational tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594115     DOI: 10.1007/BF03347022

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy.

Authors:  F Petraglia; G C Garuti; L Calza; V Roberts; L Giardino; A R Genazzani; W Vale; H Meunier
Journal:  Am J Obstet Gynecol       Date:  1991-09       Impact factor: 8.661

2.  Down-modulation of c-kit mRNA and protein expression by erythroid differentiation factor/activin A.

Authors:  M Hino; Y Nishizawa; N Tatsumi; A Tojo; H Morii
Journal:  FEBS Lett       Date:  1995-10-23       Impact factor: 4.124

3.  Inhibition of vascular endothelial cell growth by activin-A.

Authors:  S A McCarthy; R Bicknell
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

4.  Human follistatin-related protein: a structural homologue of follistatin with nuclear localization.

Authors:  D V Tortoriello; Y Sidis; D A Holtzman; W E Holmes; A L Schneyer
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

Review 5.  Changes in inhibins and activin secretion in healthy and pathological pregnancies.

Authors:  P Florio; L Cobellis; S Luisi; P Ciarmela; F M Severi; C Bocchi; F Petraglia
Journal:  Mol Cell Endocrinol       Date:  2001-06-30       Impact factor: 4.102

6.  FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins.

Authors:  L Bartholin; V Maguer-Satta; S Hayette; S Martel; M Gadoux; S Bertrand; L Corbo; C Lamadon; A M Morera; J P Magaud; R Rimokh
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

7.  Activin betaA-subunit and activin receptors in human myometrium at term and during labour.

Authors:  M Schneider-Kolsky; U Manuelpillai; C Gargett; E M Wallace
Journal:  BJOG       Date:  2001-08       Impact factor: 6.531

8.  Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family.

Authors:  K Tsuchida; K Y Arai; Y Kuramoto; N Yamakawa; Y Hasegawa; H Sugino
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

9.  Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells.

Authors:  P Florio; M Lombardo; R Gallo; C Di Carlo; S Sutton; A R Genazzani; F Petraglia
Journal:  Placenta       Date:  1996 Jul-Aug       Impact factor: 3.481

10.  Localization, secretion, and action of inhibin in human placenta.

Authors:  F Petraglia; P Sawchenko; A T Lim; J Rivier; W Vale
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

View more
  11 in total

1.  Gene expression patterns in human placenta.

Authors:  Ruchira Sood; James L Zehnder; Maurice L Druzin; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

2.  Gene expression in first trimester preeclampsia placenta.

Authors:  Sandra A Founds; Lauren A Terhorst; Kirk P Conrad; W Allen Hogge; Arun Jeyabalan; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2010-11-01       Impact factor: 2.522

Review 3.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 4.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

5.  Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid.

Authors:  Pasquapina Ciarmela; Enrrico Bloise; Peter C Gray; Patrizia Carrarelli; Md Soriful Islam; Flavio De Pascalis; Filiberto Maria Severi; Wylie Vale; Mario Castellucci; Felice Petraglia
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

6.  Porphyromonas gingivalis strain-dependent inhibition of uterine spiral artery remodeling in the pregnant rat.

Authors:  Priscilla Phillips; Mary B Brown; Ann Progulske-Fox; Xiao-Jun Wu; Leticia Reyes
Journal:  Biol Reprod       Date:  2018-11-01       Impact factor: 4.285

7.  Gene expression of four targets in situ of the first trimester maternal-fetoplacental interface.

Authors:  Sandra A Founds; Donna B Stolz
Journal:  Tissue Cell       Date:  2019-11-06       Impact factor: 2.466

8.  Circulating profile of Activin-Follistatin-Inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment.

Authors:  Eirini Bouzoni; Nikolaos Perakakis; Christos S Mantzoros
Journal:  Metabolism       Date:  2020-10-10       Impact factor: 8.694

9.  Hypoxia enhances the expression of follistatin-like 3 in term human trophoblasts.

Authors:  T Biron-Shental; W T Schaiff; E Rimon; T L Shim; D M Nelson; Y Sadovsky
Journal:  Placenta       Date:  2007-10-23       Impact factor: 3.481

10.  Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women.

Authors:  Sandra A Founds; Dianxu Ren; James M Roberts; Arun Jeyabalan; Robert W Powers
Journal:  Reprod Sci       Date:  2014-04-03       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.